Usefulness of Cone-Beam CT-Based Liver Perfusion Mapping for Evaluating the Response of Hepatocellular Carcinoma to Conventional Transarterial Chemoembolization
Open Access
- 11 February 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (4) , 713
Abstract
We investigated the cone beam computed tomography (CBCT)-based-liver-perfusion-mapping usefulness during transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) to access treatment response and predict outcomes. From October 2016 to September 2018, 42 patients with HCCs scheduled for conventional TACE were prospectively enrolled. Three reviewers evaluated the unenhanced and contrast-enhanced CBCT and CBCT-based-liver-perfusion-mapping of each tumor. Parenchymal blood volume (PBV) was measured. The operator’s judgment on the technical results was recorded. Response outcome was determined on follow-up CT or magnetic resonance imaging, according to the modified Response Evaluation Criteria in Solid Tumors. Diagnostic performance for detection of a viable tumor was evaluated using multiple logistic regression with C-statistics. CBCT-based-liver-perfusion-mapping and the maximum PBV of the tumor were significant in multiple logistic regression analysis of response (p < 0.0001, p = 0.0448, respectively), with C-statistics of 0.9540 and 0.7484, respectively. Diagnostic accuracy of operator’s judgment was 79.66% (95%CI 69.39%–89.93%). Diagnostic performance of CBCT-based-liver-perfusion-mapping showed a high concordance in three reviewers. The mean PBV of tumor, maximum PBV of tumor, and mean PBV of liver significantly decreased after TACE (each p < 0.001). In ROC curve analysis, the AUC for prediction of residual tumor by the maximum PBV of tumor after TACE was 0.7523, with 80.8% sensitivity and 60.6% specificity.Keywords
This publication has 23 references indexed in Scilit:
- CT Perfusion of the Liver: Principles and Applications in OncologyRadiology, 2014
- Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationJournal of Hepatology, 2013
- Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisationEuropean Journal of Cancer, 2013
- Intraprocedural C-Arm Dual-Phase Cone-Beam CT: Can It Be Used to Predict Short-term Response to TACE with Drug-eluting Beads in Patients with Hepatocellular Carcinoma?Radiology, 2013
- Lack of Response after Initial Chemoembolization for Hepatocellular Carcinoma: Does It Predict Failure of Subsequent Treatment?Radiology, 2012
- Volume perfusion-CT of the liver: Insights and applicationsEuropean Journal of Radiology, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- C-Arm CT Measurement of Cerebral Blood Volume in Ischemic Stroke: An Experimental Study in CaninesAmerican Journal of Neuroradiology, 2010
- Perfusion CT for the assessment of tumour vascularity: which protocol?British Journal of Radiology, 2003
- Comparison of CT Findings with Resected Specimens After Chemoembolization with Iodized Oil for Hepatocellular CarcinomaAmerican Journal of Roentgenology, 2000